TRIPS waiver may have little impact, say Indian vaccine makers

Vaccine industry insiders feel intellectual property rights is not the only or main obstacle to ensure higher access of Covid-19 vaccine

Waiving the World Trade Organization (WTO) rules on Trade-Related Aspects of Intellectual Property Rights (TRIPS) alone would not lead to increased access to vaccines across the globe, feel vaccine makers and legal experts.
 

Such a temporary lifting of intellectual property rights (IPR) to ensure higher production of vaccines during the pandemic, which India and South Africa have been pushing for, may not have an immediate implication for the local vaccine industry either, the experts felt.
 

Vaccine industry insiders feel IPR is not the only or main obstacle to ensure higher access of Covid-19 vaccine – it is more a matter